Remifentanil
- Generic Name
- Remifentanil
- Brand Names
- Ultiva
- Drug Type
- Small Molecule
- Chemical Formula
- C20H28N2O5
- CAS Number
- 132875-61-7
- Unique Ingredient Identifier
- P10582JYYK
- Background
Remifentanil (marketed by Abbott as Ultiva) is a potent ultra short-acting synthetic opioid given to patients during surgery for pain relief and adjunctive to an anaesthetic. Remifentanil is a specific mu-type-opioid receptor agonist which means it reduces sympathetic nervous system tone, and causes respiratory depression and analgesia.
- Indication
For use during the induction and maintenance of general anesthesia.
- Associated Conditions
- -
- Associated Therapies
- Immediate postoperative analgesia therapy, Induction and Maintenance of General Anesthesia, Monitored anesthesia care sedation
A Dose Finding Study of Remifentanil and Propofol for Lumbar Punctures in Children
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2019-12-02
- Lead Sponsor
- The Hospital for Sick Children
- Target Recruit Count
- 64
- Registration Number
- NCT00213239
- Locations
- 🇨🇦
The Hospital for Sick Children, Toronto, Ontario, Canada
Remifentanil as Intravenous Patient-controlled Analgesia (IVPCA) During Labour
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2014-06-23
- Lead Sponsor
- Sorlandet Hospital HF
- Target Recruit Count
- 41
- Registration Number
- NCT00202722
- Locations
- 🇳🇴
Sorlandet sykehus HF, Kristiansand, Vest-Agder, Norway
Bispectral Index as an Analgesia Monitoring in Severely Ill Patient: Effect of Remifentanyl
Not Applicable
- Conditions
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2005-11-22
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Target Recruit Count
- 40
- Registration Number
- NCT00162591
- Locations
- 🇫🇷
Surgical ICU Bichat Claude Bernard, Paris, France
Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects
Phase 4
Completed
- Conditions
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-10-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 224
- Registration Number
- NCT00158873
- Locations
- 🇳🇱
GSK Investigational Site, Zwolle, Netherlands
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath